His tone seems very confident about MSB's case regarding the FDA dispute resolution pathway for accelerated approval - focusing on unmet need and excellent safety profiling of Rem-L. Love it.
His tone seems very confident about MSB's case regarding the FDA...
-
- There are more pages in this discussion • 248 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.000(0.00%) |
Mkt cap ! $1.667B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1826 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 6118 | 1 |
View Market Depth
| Last trade - 09.49am 12/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable